[Recurrent miscarriage or failed in-vitro fertilization: antibodies against annexin V, cardiolipin, beta-2-glycoprotein-1 and APC-resistance].

Abstract:

UNLABELLED:Antibodies against annexin-V, a potent anticoagulant abundant in placental tissues, were recently controversially reported to be associated with recurrent miscarriages or failures of in-vitro-fertilization (IVF) attempts. PATIENTS, MATERIAL, METHODS:We screened 56 women (34.7 +/- 4.3 years of age: mean +/- 1 SD) with recurrent IVF failures and/or early pregnancy losses for resistance against activated protein C, lupus anticoagulant and antibodies against annexin V, cardiolipin or beta(2)-glycoprotein-1. Among them the prevalence of APC-R (8/56, 14%) and elevated levels of IgG- or IgM-anti-cardiolipin antibodies (7/56, 12%) were more common than elevated levels of (IgG or IgM) antibodies against beta(2)-glycoprotein-1 (3/56, 5%) or annexin-V (1/56, 2%). 42 (75%) of the women had another IVF-attempt after this haemostaseological evaluation and received low molecular weight heparin and/ or acetylsalicylic acid in the case of positivity for APC-resistance, lupus anticoagulant or antibodies against annexin V, cardiolipin or beta(2)-glycoprotein-1. RESULTS:The outcome of these IVF-attempts were 19 pregnancies (34%): 4 early miscarriages (7%) and 15 so far uncomplicated pregnancies (27%). The only woman with an elevated anti-annexin V (IgG) level had had 7 IVF before and received 40 mg Enoxaparin (Lovenox) subcutaneously once daily during the 8(th) IVF, which resulted in a healthy pregnancy. DISCUSSION, CONCLUSION:Our findings suggest that among women with recurrent IVF failures anti-annexin V antibody positivity is less prevalent than APC-resistance, lupus anticoagulant (LA) or elevated levels of antibodies against cardiolipin, beta(2)-glycoprotein-1 and that the IVF-result of women with APC-R, LA or with elevated levels of antibodies against annexin V, cardiolipin or beta(2)-glycoprotein might be positively influenced by low molecular weight heparin.

journal_name

Hamostaseologie

journal_title

Hamostaseologie

authors

Halbmayer WM,Feichtinger W,Kindermann C,Prendinger B,Böhm M

keywords:

subject

Has Abstract

pub_date

2005-11-01 00:00:00

pages

391-3

issue

4

eissn

0720-9355

issn

2567-5761

pii

05040391

journal_volume

25

pub_type

杂志文章
  • DOAC use in patients with chronic kidney disease.

    abstract::Direct oral anticoagulants (DOACs) are increasingly prescribed substances in patients with indication for effective anticoagulation. Patients with chronic kidney disease (CKD) have a high burden of cardiovascular risk and are more likely to develop atrial fibrillation (AF) than patients without CKD. Patients with mild...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-17-01-0003

    authors: Kcükköylü S,Rump LC

    更新日期:2017-01-01 00:00:00

  • Do we need antiplatelet therapy in thrombocytosis? Pro. Diagnostic and pathophysiologic considerations for a treatment choice.

    abstract::Thrombocytosis (defined as platelets >450 x 109/l) has several aetiologies. After having excluded spurious thrombocytosis (e. g., due to microspherocytes, schistocytes, cryoglobulins, or bacteria), the differential diagnosis of true thrombocytosis encompasses secondary causes (as diverse as inflammation, infection, ma...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-11-0074

    authors: Alberio L

    更新日期:2016-11-07 00:00:00

  • [Documentation of haemophilia treatment supported by the German Hemophilia Registry].

    abstract::The DHR (Deutsches Hämophilieregister, German Haemophilia Register) records patient data on haemophilia A, haemophilia B, von Willebrand disease, and other coagulation factor deficiency disorders. The DHR has been online since 2009. The participation in the DHR leads to additional administrative workload for the hospi...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Haschberger B,Hesse J,Heiden M,Seitz R,Schramm W

    更新日期:2010-11-01 00:00:00

  • [Risk assessment of recurrence of venous thromboembolism].

    abstract::Recurrent venous thromboembolism is associated with increased mortality in 5-9% of the patients. On the other hand prolonged anticoagulation can increase the bleeding risk which can also be responsible for an increased mortality. Therefore, it is necessary to validate the recurrence risk of venous thromboembolism on a...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/ha-1144

    authors: Lindhoff-Last E

    更新日期:2011-02-01 00:00:00

  • Understanding and Preventing Placenta-Mediated Pregnancy Complications.

    abstract::Placenta-mediated pregnancy complications are clinically important conditions and include preeclampsia, placental abruption, intrauterine growth restriction, and late fetal loss. Pathophysiology is complex, and may be linked to prothrombotic disorders such as antiphospholipid syndrome, whose understanding is still evo...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/a-1184-8388

    authors: Skeith L,Blondon M,Ní Áinle F

    更新日期:2020-08-01 00:00:00

  • Hermansky-Pudlak syndrome. Overview of clinical and molecular features and case report of a new HPS-1 variant.

    abstract::Hermansky-Pudlak syndrome (HPS) is a rare, autosomal recessive disorder affecting lysosome-related organelles (LRO), including dense platelet granules. HPS causes oculocutaneous hypopigmentation, bleeding diathesis and granulomatous colitis or pulmonary fibrosis. To date, there is no curative treatment and the clinica...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-06-0024

    authors: Sánchez-Guiu I,Torregrosa JM,Velasco F,Antón AI,Lozano ML,Vicente V,Rivera J

    更新日期:2014-01-01 00:00:00

  • Arterial thrombus formation. Novel mechanisms and targets.

    abstract::Platelet and coagulation factor-dependent thrombus formation is critical to limit posttraumatic blood loss at sites of vascular injury. However, under pathological conditions like rupture of an atherosclerotic plaque, it may also lead to vessel occlusion causing myocardial infarction or stroke. Therefore, antithrombot...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Hagedorn I,Vögtle T,Nieswandt B

    更新日期:2010-08-01 00:00:00

  • [Is the generally accepted therapeutic benefit of exercise training in patients with peripheral arterial occlusive disease evidence based? Analysis of the Cochrane review].

    abstract::When assessing the quality of clinical trials in intermittent claudication, on principle the same strict biometric and medical standards need to be applied for studies on the effect of walking exercise as for conservative drug treatment studies. However, as demonstrated by a recent review of the Cochrane Collaboration...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Amendt K

    更新日期:2006-08-01 00:00:00

  • [Pathophysiology of chemotherapy-associated thrombosis].

    abstract::Epidemiological studies revealed that most antineoplastic agents and regimes enhance the risk of venous and arterial thromboembolic events in cancer patients. The purpose of this article is to review clinical and pathophysiological data related to chemotherapy-associated thromboembolism under special consideration of ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Lechner D,Weltermann A

    更新日期:2009-01-01 00:00:00

  • Thrombin generation and venous thromboembolism.

    abstract::Venous thromboembolism is a chronic and potential fatal disease. Determination of recurrence risk is time-consuming and costly, and sometimes not feasible: many patients carry more than one risk factor, the relevance of some factors with regard to risk of recurrence is unknown, and existence of thus far unknown risk f...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Eichinger S

    更新日期:2008-02-01 00:00:00

  • [Fibrin monomer and factor XIII: a new concept for unexplained intraoperative coagulopathy].

    abstract::Unexplained intraoperative coagulopathies continue to be a diagnostic and therapeutic dilemma. The pathophysiology behind unexplained intraoperative coagulopathies is of great variety and complexity (preexisting coagulopathies, dilutional coagulopathy, interactions of medications etc.). We have shown in prospective st...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Korte W

    更新日期:2006-08-01 00:00:00

  • Coagulation Signalling and Metabolic Disorders: Lessons Learned from Animal Models.

    abstract::Nutrient excess in obesity drives metabolic reprogramming in multiple tissues involving extensive interorgan and intercellular crosstalk. Experimental and clinical studies show that prolonged nutrient excess often compromises metabolic adaptation propagating proobesogenic and proinflammatory responses. Chronic inflamm...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0039-1688800

    authors: Madhusudhan T,Ruf W

    更新日期:2019-06-01 00:00:00

  • Feasibility and Results of a Mobile Haemophilia Outpatient Care Pilot Project.

    abstract:INTRODUCTION: Regular visits at haemophilia treatment centres (HTCs) in rural regions are often dependent on the access to a private car due to lack of or limited availability of public means. Therefore, a mobile haemophilia outpatient care (MHOC) concept providing home visits to haemophilia patients has been developed...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/s-0038-1654721

    authors: Eichler H,Schleicher C,Heine S,Graf N,von Mackensen S

    更新日期:2018-08-01 00:00:00

  • [The importance of quality assurance in molecular genetic laboratories].

    abstract::Several challenges arise from the wide application of molecular genetic analyses, among them the need to introduce rules to evaluate molecular genetic test systems as well as test laboratories. This article specifically addresses laboratories performing molecular genetic tests for diagnosis, prevention and therapy of ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Mannhalter C

    更新日期:2010-05-01 00:00:00

  • The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease. An emerging field.

    abstract::Coronary heart disease and stroke, the deadliest forms of cardiovascular disease (CVD), are mainly caused by atherosclerosis, a chronic inflammatory disease of the artery wall driven by maladaptive immune responses in the vessel wall. Various risk factors for CVD influence this pathogenic process, including diabetes m...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-10-0052

    authors: Polyzos KA,Ketelhuth DF

    更新日期:2015-01-01 00:00:00

  • Recurrent cerebral ischaemia in a pregnant woman with patent foramen ovale II° and thrombophilia.

    abstract::This case report concerns a pregnant multipara (age: 27 years) in the 16th gestational week. She developed a sudden onset of paraesthesia in her left lower arm although injecting dalteparin 5000 IU once daily subcutaneously (s. c.) due to a heterozygous factor V Leiden mutation and a prior miscarriage in the first pre...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.5482/HAMO-14-03-0022

    authors: Hecking C,Hendelmeier M,von Bardeleben R,Gröschel K,Schinzel H

    更新日期:2014-01-01 00:00:00

  • Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen.

    abstract::In Germany one-third of the women in fertile age use combined oral contraceptives (COCs), which consist mostly of ethinylestradiol (EE) and a synthetic progestin. Older COCs with norethisterone or levonorgestrel have a lower risk for venous thromboembolism (VTE) than newer COCs with desogestrel, drospirenone, or gesto...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0039-1677806

    authors: Rott H

    更新日期:2019-02-01 00:00:00

  • [Replacement therapy of coagulation factor preparations: antithrombin, FFP, PPSB, FXIII, rFVIIa].

    abstract::Replacement therapy of coagulation factor preparations (AT, FFP, PPSB, FXIII, rFVIIa) are frequently used on the Intensive Care Units. Indications, dosage, specific effects and side effects have to be considered. ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1267/hämo05020209

    authors: Scharrer I

    更新日期:2005-05-01 00:00:00

  • Tissue factor pathways linking obesity and inflammation.

    abstract::Obesity is a major cause for a spectrum of metabolic syndrome-related diseases that include insulin resistance, type 2 diabetes, and steatosis of the liver. Inflammation elicited by macrophages and other immune cells contributes to the metabolic abnormalities in obesity. In addition, coagulation activation following t...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-11-0068

    authors: Ruf W,Samad F

    更新日期:2015-01-01 00:00:00

  • [Pathophysiology of acute coronary syndrome].

    abstract::This article reviews the current understanding of the pathophysiology of acute coronary syndrome and how these concepts have altered our clinical approach to the acute phase of coronary heart disease. Thrombosis due to erosion or, in most cases, rupture of a vulnerable atherosclerotic plaque underlies most acute coron...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Hölschermann H,Tillmanns H,Bode C

    更新日期:2006-05-01 00:00:00

  • Acquired Haemophilia A Associated with Subsequent Hepatocellular Carcinoma.

    abstract::Acquired haemophilia A (AHA) is a rare autoimmune disease caused by antibodies directed against clotting factor VIII. About half of cases are idiopathic, but AHA may also be secondary to autoimmune, dermatologic, or oncologic diseases. In approximately 10% of non-idiopathic cases, the disease occurs after or with the ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/s-0038-1668570

    authors: Pacholczak R,Bazan-Socha S,Zdziarska J,Iwaniec T,Walocha JA,Musiał J,Dropiński J

    更新日期:2019-02-01 00:00:00

  • Screening for haemorrhagic disorders in paediatric patients by means of a questionnaire.

    abstract:AIM:In children, screening for haemorrhagic disorders is further complicated by the fact that infants and young children with mild disease in many cases most likely will not have a significant history of easy bruising or bleeding making the efficacy of a questionnaire even more questionable. PATIENTS, METHODS:We compa...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Music I,Novak M,Acham-Roschitz B,Muntean W

    更新日期:2009-10-01 00:00:00

  • [The unstable carotid stenosis: definition and biological processes].

    abstract::The occurrence of cerebral or retinal ischemic symptoms ipsilateral to high-grade internal carotid artery (ICA) stenosis indicates a status of instability with a substantial risk for future major stroke. Additionally, the detection of microembolic signals downstream of ICA stenosis is predictive for future cerebral is...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Sitzer M,Trostdorf F

    更新日期:2003-05-01 00:00:00

  • [Antithrombotic therapy of acute coronary syndromes].

    abstract::Recent advances in the diagnosis and the treatment of acute coronary syndromes (ACS) have led to a substantial reduction of major coronary events, to an improvement in patient outcome and the definition of new guidelines. Current strategies for the treatment of patients with non-ST-elevation ACS recommend a combined a...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Hölschermann H

    更新日期:2007-12-01 00:00:00

  • Cofactor-Independent Antiphospholipid Antibodies: Implications for Pathogenesis, Diagnosis, and Treatment of Antiphospholipid Syndrome.

    abstract::The antiphospholipid syndrome (APS) has occupied haemostaseologists, rheumatologists and obstetricians since its initial description 35 years ago. Its name has been coined because of the antibodies against phospholipids which were the common property of affected patients. In particular, the pathogenesis of APS has bee...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0038-1675355

    authors: Lackner KJ,Müller-Calleja N

    更新日期:2019-06-01 00:00:00

  • [Congenital and acquired thrombocytopenias].

    abstract::An overview is given on congenital and acquired thrombocytopenias, their pathophysiology, symptoms, diagnosis and therapy with emphasizing heparin-induced thrombocytopenia (HIT) and the thrombotic thrombocytopenic purpura (TTP). ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Scharf RE

    更新日期:2003-11-01 00:00:00

  • Old and new anticoagulants.

    abstract::Vitamin-K-antagonists (VKA) and heparins have been complementary anticoagulants for prevention and treatment of thrombosis for almost 70 years. In contrast to heparins, VKA have not been modified pharmacologically, however treatment surveillance has improved by introducing INR and self-monitoring/management. Disclosur...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/ha-1149

    authors: Harbrecht U

    更新日期:2011-02-01 00:00:00

  • VKCFD2 - from clinical phenotype to molecular mechanism.

    abstract::Vitamin K 2,3-epoxide reductase complex, subunit 1 (VKORC1) is an enzyme essential for the vitamin K cycle. VKORC1 catalyses the reduction of vitamin K 2,3-epoxide to the quinone form of vitamin K and further to vitamin K hydroquinone. The generated vitamin K hydroquinone serves as substrate for the enzyme γ-glutamyl-...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Czogalla KJ,Watzka M,Oldenburg J

    更新日期:2016-11-08 00:00:00

  • Anticoagulation during and after acute coronary syndrome.

    abstract::Current antithrombotic therapy in patients with acute coronary syndrome (ACS) comprises antiplatelet and anticoagulant therapy. Dual antiplatelet therapy composed of aspirin plus a third generation P2Y12 inhibitor (prasugrel or ticagrelor) represents the gold standard, while aspirin plus second generation P2Y12 inhibi...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-13-09-0048

    authors: Ahrens I,Bode C,Zirlik A

    更新日期:2014-01-01 00:00:00

  • Apixaban for the Treatment of Chronic Disseminated Intravascular Coagulation: A Report of Two Cases.

    abstract::Characteristic features of disseminated intravascular coagulation (DIC) are the opposing risks of bleeding (due to consumptive coagulopathy and hyperfibrinolysis) and organ failure (due to widespread microvascular thromboses). The purpose of anticoagulation in DIC is to attenuate excessive thrombin generation and fibr...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/s-0038-1675386

    authors: Janjetovic S,Holstein K,Dicke C,Bokemeyer C,Langer F

    更新日期:2019-08-01 00:00:00